Rohto Pharmaceutical Co.,Ltd.
4527
Pozycja w akcjach
#3845
Established in Osaka, Japan, in 1899, Rohto Pharmaceutical Co.,Ltd. is a global... Established in Osaka, Japan, in 1899, Rohto Pharmaceutical Co.,Ltd. is a global entity engaged in the development, manufacturing, and marketing of a diverse array of pharmaceutical goods, beauty products, and nutritional supplements. Their comprehensive product line includes various ophthalmic solutions such as eye drops, contact lens care products, and eye washes. For skincare, they offer facial treatments like cleansers, toners, and creams, in addition to specialized medicated preparations for the skin. The company's offerings also extend to internal medicines, encompassing digestive aids, herbal remedies, and dietary supplements. Furthermore, they supply over-the-counter medications and deliver beauty and health services via dedicated counters. The company rebranded from Yamada Pharmaceutical to Rohto Pharmaceutical Co.,Ltd. in September 1949.
Cena akcji
$19.03
Kapitalizacja rynkowa
$4.30B
Zmiana (1 dzień)
0.15%
Zmiana (1 rok)
16.15%
Kraj
JP
Handel Rohto Pharmaceutical Co.,Ltd. (4527)
Kategoria
Consumer Defensive
Zyski dla Rohto Pharmaceutical Co.,Ltd. (4527)
Zyski w Jun 2026 TTM: $303.71M
Według najnowszych raportów finansowych Rohto Pharmaceutical Co.,Ltd., obecny zysk firmy wynosi $303.71M. W roku 2024 firma osiągnęła zysk w wysokości $274.31M, wzrost w porównaniu do zysku z roku 2023, który wynosił $258.26M. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy Rohto Pharmaceutical Co.,Ltd. od 2008 do 2026
Zyski na koniec każdego roku
| Rok | Zyski | Zmień |
|---|---|---|
| 2026 (TTM) | $303.71M | 7.55% |
| 2025 | $282.40M | 2.95% |
| 2024 | $274.31M | 6.21% |
| 2023 | $258.26M | 12.49% |
| 2022 | $229.58M | 10.53% |
| 2021 | $207.71M | 2.77% |
| 2020 | $202.12M | 37.64% |
| 2019 | $146.85M | -7.24% |
| 2018 | $158.31M | 19.53% |
| 2017 | $132.44M | 4.19% |
| 2016 | $127.12M | 10.88% |
| 2015 | $114.65M | -19.00% |
| 2014 | $141.54M | -2.14% |
| 2013 | $144.64M | -14.82% |
| 2012 | $169.81M | 4.81% |
| 2011 | $162.02M | 21.98% |
| 2010 | $132.83M | 41.40% |
| 2009 | $93.94M | -24.26% |
| 2008 | $124.03M | 0.00% |
Zyski podobnych firm lub konkurentów
| Firma | Zyski | Różnica w zyskach | Kraj |
|---|---|---|---|
| $20.38B | 6,609.37% |
US
|
|
| $9.83B | 3,135.44% |
FR
|
|
| $2.94B | 868.36% |
US
|
|
| $1.55B | 410.35% |
IN
|
|
| $517.00M | 70.23% |
US
|
